dabigatran has been researched along with Left Ventricular Hypertrophy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alatawi, Y; Alghamdi, BS; Alshehri, FS; Balabagno, AO; Chen, Y; Durmanova, V; Evangelista, LS; Hromadka, T; Javor, J; Ji, Q; Jiao, J; Kralova, M; Kurdi, M; Labban, S; Li, X; Li, Y; Lv, Q; Minarik, G; Ocenasova, A; Pagsibigan, JS; Parnicka, Z; Reznakova, V; Shawkatova, I; Shen, ZJ; Tian, X; Tu, S; Tuazon, JA; Vaseckova, B; Wang, XY; Wang, Z; Xue, Y; Zeng, LX; Zhang, S; Zhang, ZH; Zuo, C | 1 |
| Angeli, F; Brueckmann, M; Connolly, SJ; Di Pasquale, G; Ezekowitz, MD; Kleine, E; Lip, GYH; Mazzotta, G; Reboldi, G; Verdecchia, P; Wallentin, L; Yusuf, S | 1 |
| Ansell, J; Chang, P; Ezekowitz, MD; Fonarow, GC; Gersh, B; Go, AS; Hylek, E; Kim, S; Kowey, P; Lopes, RD; Mahaffey, KW; Peterson, ED; Piccini, JP; Singer, DE; Steinberg, BA; Thomas, L | 1 |
| Bettex, D; Bosshart, M; Brand, B; Schlicker, A; Spahn, DR; Stein, P | 1 |
1 trial(s) available for dabigatran and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Administration Schedule; Electrocardiography; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Risk Factors; Stroke; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling; Warfarin | 2018 |
3 other study(ies) available for dabigatran and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin II; Animals; Antithrombins; Atrial Fibrillation; Body Mass Index; Catheter Ablation; Cohort Studies; Dabigatran; Dogs; Embolism; Factor Xa Inhibitors; Female; Genotype; Hemorrhage; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Middle Aged; Norepinephrine; Obesity; Polymorphism, Single Nucleotide; Retrospective Studies; Rivaroxaban; Stroke; Sympathectomy | 2017 |
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebrovascular Disorders; Clopidogrel; Comorbidity; Dabigatran; Drug Synergism; Female; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Hospitalization; Humans; Hypertrophy, Left Ventricular; Logistic Models; Male; Middle Aged; Models, Cardiovascular; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Risk; Ticlopidine; Treatment Outcome | 2013 |
Dabigatran anticoagulation and Stanford type A aortic dissection: lethal coincidence: Case report with literature review.
Topics: Aged; Anticoagulants; Aortic Aneurysm, Thoracic; Aortic Dissection; Aortic Valve Insufficiency; Atrial Fibrillation; Benzimidazoles; Blood Coagulation Factors; Blood Coagulation Tests; Blood Component Transfusion; Cardiac Tamponade; Cardiopulmonary Bypass; Dabigatran; Emergencies; Fatal Outcome; Heart Valve Prosthesis Implantation; Hemodiafiltration; Heparin; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Pyridines; Shock, Hemorrhagic; Thrombelastography; Tranexamic Acid | 2014 |